These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 30697366)

  • 21. Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management.
    Parrinello CM; Selvin E
    Curr Diab Rep; 2014; 14(11):548. PubMed ID: 25249070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring.
    Beck R; Steffes M; Xing D; Ruedy K; Mauras N; Wilson DM; Kollman C;
    Pediatr Diabetes; 2011 Dec; 12(8):690-5. PubMed ID: 21496193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What do we need beyond hemoglobin A1c to get the complete picture of glycemia in people with diabetes?
    Hinzmann R; Schlaeger C; Tran CT
    Int J Med Sci; 2012; 9(8):665-81. PubMed ID: 23055818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of glycemic variability in well-controlled type 2 diabetes mellitus.
    Chon S; Lee YJ; Fraterrigo G; Pozzilli P; Choi MC; Kwon MK; Chin SO; Rhee SY; Oh S; Kim YS; Woo JT
    Diabetes Technol Ther; 2013 Jun; 15(6):455-60. PubMed ID: 23617251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Accuracy of Hemoglobin A1c and Fructosamine Evaluated by Long-Term Continuous Glucose Monitoring in Patients with Type 2 Diabetes Undergoing Hemodialysis.
    Bomholt T; Rix M; Almdal T; Knop FK; Rosthøj S; Heinrich NS; Jørgensen MB; Larsson A; Hilsted L; Feldt-Rasmussen B; Hornum M
    Blood Purif; 2022; 51(7):608-616. PubMed ID: 34583354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1,5-Anhydroglucitol and glycated albumin in glycemia.
    Koga M
    Adv Clin Chem; 2014; 64():269-301. PubMed ID: 24938022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(20):1-58. PubMed ID: 23074525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical validity of a self-test fructosamine in outpatient diabetic management.
    Cefalu WT; Wang ZQ; Redmon E; Bell-Farrow AD; McBride D; King T
    Diabetes Technol Ther; 1999; 1(4):435-41. PubMed ID: 11474829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study.
    Ding N; Kwak L; Ballew SH; Jaar B; Hoogeveen RC; Ballantyne CM; Sharrett AR; Folsom AR; Heiss G; Salameh M; Coresh J; Hirsch AT; Selvin E; Matsushita K
    Atherosclerosis; 2018 Jul; 274():86-93. PubMed ID: 29753232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes.
    Danese E; Montagnana M; Nouvenne A; Lippi G
    J Diabetes Sci Technol; 2015 Mar; 9(2):169-76. PubMed ID: 25591856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous Glucose Monitoring: A Brief Review for Primary Care Practitioners.
    Ajjan R; Slattery D; Wright E
    Adv Ther; 2019 Mar; 36(3):579-596. PubMed ID: 30659511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential Markers of Dietary Glycemic Exposures for Sustained Dietary Interventions in Populations without Diabetes.
    Feskens E; Brennan L; Dussort P; Flourakis M; Lindner LME; Mela D; Rabbani N; Rathmann W; Respondek F; Stehouwer C; Theis S; Thornalley P; Vinoy S
    Adv Nutr; 2020 Sep; 11(5):1221-1236. PubMed ID: 32449931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fructosamine and glycated hemoglobin as biomarkers of glycemic control in people with type 2 diabetes mellitus and cancer (GlicoOnco study).
    Toyoshima MTK; Cukier P; Damascena AS; Batista RL; de Azevedo Correa F; Zanatta Kawahara E; Minanni CA; Hoff AO; Nery M
    Clinics (Sao Paulo); 2023; 78():100240. PubMed ID: 37390617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
    Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
    Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations between features of glucose exposure and A1C: the A1C-Derived Average Glucose (ADAG) study.
    Borg R; Kuenen JC; Carstensen B; Zheng H; Nathan DM; Heine RJ; Nerup J; Borch-Johnsen K; Witte DR;
    Diabetes; 2010 Jul; 59(7):1585-90. PubMed ID: 20424232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of a Study Comparing Glycated Albumin to Other Glycemic Indices.
    Desouza CV; Holcomb RG; Rosenstock J; Frias JP; Hsia SH; Klein EJ; Zhou R; Kohzuma T; Fonseca VA
    J Clin Endocrinol Metab; 2020 Mar; 105(3):677-87. PubMed ID: 31650161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of glycemia in diabetes mellitus: hemoglobin A1c.
    Saudek CD; Kalyani RR; Derr RL
    J Assoc Physicians India; 2005 Apr; 53():299-305. PubMed ID: 15987016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1,5-anhydroglucitol as a useful marker for assessing short-term glycemic excursions in type 1 diabetes.
    Seok H; Huh JH; Kim HM; Lee BW; Kang ES; Lee HC; Cha BS
    Diabetes Metab J; 2015 Apr; 39(2):164-70. PubMed ID: 25922811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fructosamine and Glycated Albumin and the Risk of Cardiovascular Outcomes and Death.
    Selvin E; Rawlings AM; Lutsey PL; Maruthur N; Pankow JS; Steffes M; Coresh J
    Circulation; 2015 Jul; 132(4):269-77. PubMed ID: 26022911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemoglobin A1c and Fructosamine Evaluated in Patients with Type 2 Diabetes Receiving Peritoneal Dialysis Using Long-Term Continuous Glucose Monitoring.
    Bomholt T; Feldt-Rasmussen B; Butt R; Borg R; Sarwary MH; Elung-Jensen T; Almdal T; Knop FK; Nørgaard K; Ranjan AG; Larsson A; Rix M; Hornum M
    Nephron; 2022; 146(2):146-152. PubMed ID: 34731864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.